Company updateNDTV Profit
Brokerages revise targets for Honasa, Gland, Siemens ahead of Muhurat trading
Positive+2
GreyOak summary
Brokerages revised target prices and earnings estimates for Honasa Consumer, Gland Pharma, Siemens, and Sai Life Sciences ahead of the Muhurat trading session. Honasa and Gland saw target increases due to strong performance, while Siemens received upgrades on resilient revenue. The moves reflect varying broker views on growth prospects and valuations.
What it affects
- Gland PharmaGLANDPositive +2
Targets raised on strong US salesRolling sentiment Positive +64
- Honasa ConsumerHONASAPositive +1
Brokerages maintain Buy/Sell ratings with revised targetsRolling sentiment Positive +71
- SiemensSIEMENSPositive +1
Targets raised on resilient revenue and order inflows.Rolling sentiment Positive +26
Source
Read the original at NDTV ProfitMore Gland Pharma news
- Five Stocks To Buy Today, November 11: Gland Pharma, Sansera Engineering, Union Bank, And MoreNDTV Profit · Stock view ·
- Gland Pharma shares rally 8% to hit 4-year-high post strong Q2Moneycontrol · Results ·
- Gland Pharma shares jump 7% to 52-week highCNBC-TV18 · Stock view ·
- Pharma shares shine: Sai, Gland, Divi's, Laurus, Glenmark surge up to 9%Business Standard · Stock view ·
- Divis, Gland, Sai Life Sciences shares hit 52-week highsBusiness Today · Stock view ·